Japanese firm Daiichi wants to go alone in search of targeted cancer drugs ...Middle East

AstraZeneca Plc and Daiichi's breast cancer drug Enhertu is based off of Daiichi's antibody-drug conjugate platform DXd, and was the top-selling ADC globally in 2023

Hence then, the article about japanese firm daiichi wants to go alone in search of targeted cancer drugs was published today ( Tuesday 17/09/2024 - 07:12 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Japanese firm Daiichi wants to go alone in search of targeted cancer drugs )

Also on site :

• Oil Prices Jump After U.S. Strikes Iranian Missile Sites
• Yatsen Announces First Quarter 2026 Financial Results
• Call for entries: Europe’s Leading Start-up Hubs 2027